Publications
61
Citations
1,405
Est. group size
~3
Recurring co-author estimate
Active years
26
Publishing since 2000
Typically publishes in teams of ~13 · 9% small-team papers (≤3 authors) · across 15 venues
- A pilot survey into the landscape of neuro-oncology care in the community
The Oncologist · 2025
- A Pilot Survey Into the Landscape of Neuro-oncology Care in the Community (P3-6.003)
Neurology · 2025
- Recurrent high grade serous endometrial cancer with brain metastases: Immunotherapy confers improved quality of life and survival
Gynecologic Oncology Reports · 2024
- Sex Difference in Disease-Related Adverse Events Post-Diagnosis of Lung Cancer Brain Metastases in Medicare Individuals ≥ 66 Years of Age
Cancers · 2024
- Ectopic Intranasal Chordoma Recurrence following Sublabial Transseptal Transsphenoidal Resection: Case Report and Literature Review
Journal of Neurological Surgery Part B Skull Base · 2024
- DISP-06. THE IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON TREATMENT DELAYS FOR GLIOBLASTOMA
Neuro-Oncology · 2024
- DISP-04. SEX DIFFERENCES IN LUNG CANCER BRAIN METASTASES ADVERSE EVENTS
Neuro-Oncology · 2024
- CTIM-25. PHASE2B/3 STUDY OF NEOANTIGEN-SPECIFIC T CELL IMMUNOTHERAPY IN NEWLY DIAGNOSED O6 – METHYLGUANINE METHYLTRANSFERASE UNMETHYLATED (MGMT -) GLIOBLASTOMA
Neuro-Oncology · 2024
- Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial
Cell Reports Medicine · 2023
- Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series
British Journal of Neurosurgery · 2023
- Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series
Figshare · 2023
- Multi-institutional randomized phase 3 trial comparing cancer stem cell-targeted versus physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135).
Journal of Clinical Oncology · 2022
- Abstract CT224: Multi-institutional randomized phase-3 trial comparing cancer stem cell-targeted vs physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135)
Cancer Research · 2022
- Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting
Neuro-Oncology Practice · 2022
- CTNI-17. A MULTI-INSTITUTIONAL RANDOMIZED CLINICAL TRIAL COMPARING ASSAY - GUIDED CHEMOTHERAPY WITH PHYSICIAN-CHOICE TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA (NCT03632135)
Neuro-Oncology · 2022
- Neuro-Oncology×8
- Journal of Clinical Oncology×3
- International Journal of Radiation Oncology*Biology*Physics×2
- Cancer Research×2
- Oxford University Press eBooks×2
- Denise Leung
Medicine · University of Michigan
- Arushi Tripathy
Medicine · University of Michigan
- Ashish H. Shah
Medicine · University of Michigan
- Erin O’Farrell
Medicine · Indiana University
- J. Bradley Elder
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile